Bilateral nephrolithiasis and upper tract transitional cell carcinoma in horseshoe kidney.

IF 0.9 4区 医学 Q4 UROLOGY & NEPHROLOGY Current Urology Pub Date : 2024-09-01 Epub Date: 2024-09-20 DOI:10.1097/CU9.0000000000000109
Jacob M Gaines, Eric J Macdonald, Arun Rai, David Hoenig, Arthur Smith, Zeph Okeke, Tareq Aro
{"title":"Bilateral nephrolithiasis and upper tract transitional cell carcinoma in horseshoe kidney.","authors":"Jacob M Gaines, Eric J Macdonald, Arun Rai, David Hoenig, Arthur Smith, Zeph Okeke, Tareq Aro","doi":"10.1097/CU9.0000000000000109","DOIUrl":null,"url":null,"abstract":"<p><p>Nephroureterectomy is currently the criterion-standard treatment for high-grade upper tract urothelial carcinoma (UTUC). Current guidelines and expert opinions propose some exceptions to this approach based on patient characteristics, disease status, and function of the contralateral kidney. We present a rare case of a patient with horseshoe kidney, bilateral large nephrolithiasis, high-grade UTUC in one moiety, and relative parenchymal thinning of the contralateral side. The patient was treated with a percutaneous, minimally invasive, nephron sparing approach. The patient also had intracollecting system instillations of gemcitabine and docetaxel. Minimally invasive percutaneous resection of high-grade UTUC is a safe procedure in select cases. Current guidelines may not apply to all patients; unique scenarios with UTUC may require personalized decision-making and treatment at specialized centers.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337981/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CU9.0000000000000109","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Nephroureterectomy is currently the criterion-standard treatment for high-grade upper tract urothelial carcinoma (UTUC). Current guidelines and expert opinions propose some exceptions to this approach based on patient characteristics, disease status, and function of the contralateral kidney. We present a rare case of a patient with horseshoe kidney, bilateral large nephrolithiasis, high-grade UTUC in one moiety, and relative parenchymal thinning of the contralateral side. The patient was treated with a percutaneous, minimally invasive, nephron sparing approach. The patient also had intracollecting system instillations of gemcitabine and docetaxel. Minimally invasive percutaneous resection of high-grade UTUC is a safe procedure in select cases. Current guidelines may not apply to all patients; unique scenarios with UTUC may require personalized decision-making and treatment at specialized centers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
马蹄肾双侧肾结石及上尿路移行细胞癌
肾切除术是目前治疗高级别上尿路上皮癌(UTUC)的标准疗法。目前的指南和专家意见根据患者的特征、疾病状态和对侧肾脏的功能提出了一些例外情况。我们介绍了一例罕见病例,患者患有马蹄肾、双侧大块肾结石、一侧肾脏为高级别UTUC、对侧肾脏实质相对较薄。患者接受了经皮、微创、保留肾小球的治疗。患者还接受了吉西他滨和多西他赛的体内注射治疗。经皮微创切除高级别UTUC在特定病例中是一种安全的手术。目前的指南可能并不适用于所有患者;UTUC的特殊情况可能需要在专业中心进行个性化决策和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Urology
Current Urology Medicine-Urology
CiteScore
2.30
自引率
0.00%
发文量
96
期刊最新文献
Bilateral nephrolithiasis and upper tract transitional cell carcinoma in horseshoe kidney. Relationship between serum vitamin D concentration and parameters of gonadal function in infertile male patients. Peritoneal interposition flap reduces symptomatic lymphocele following transperitoneal robot-assisted radical prostatectomy and pelvic lymph node dissection: An updated meta-analysis. A comparison of the efficacy of dutasteride on reducing lower urinary tract symptoms among patients with small versus large benign prostatic hyperplasia. Can serum tumor marker densities according to tumor volume and testicle size be used to predict progression in patients with testicular cancer?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1